関連する実験動画

Updated: Jan 7, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.9K

EGFR- TKIで治療されたEGFR変異性NSCLCにおけるPD- L1発現とインタースティシャル肺疾患リスクとの関連

Yutaka Takahara1, Ryudai Abe2, Sumito Nagae2

  • 1Department of Respiratory Medicine, Kanazawa Medical University, Ishikawa, Japan takahara@kanazawa-med.ac.jp.

In vivo (Athens, Greece)
|January 2, 2026
PubMed
まとめ

No abstract available in PubMed .

キーワード:
非小細胞肺がん皮質の成長因子受容体インタースティシャル肺疾患変異プログラムされた死のリガンド 1

さらに関連する動画

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.0K
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.5K

関連する概念動画